期刊文献+

CD137-CD137L与1型糖尿病的相关性研究进展

Research progress on the correlation between CD137-CD137L and type 1 diabetes
原文传递
导出
摘要 1型糖尿病(type 1 diabetes mellitus,T1DM)是一种多因素免疫介导的与自身免疫密切相关的疾病,其发病机制尚不完全明确,近年来发现,T细胞及其细胞亚群的活化与T1DM发生密切相关,而CD137-CD137L信号通路是T细胞活化的重要协调分子。文章就CD137-CD137L共刺激通路的相互作用及在T1DM发生、发展及免疫治疗中的影响进行综述。 Type 1 diabetes(T1DM)is a multifactorial immune mediated disease closely related to autoimmunity,and its pathogenesis is not completely clear.In recent years,it has been found that the activation of T cells and their subsets is closely related to the occurrence of T1DM,and CD137-CD137L signaling pathway is an important co modulator of T cell activation.The interaction of CD137-CD137L costimulatory pathway and its influence on the occurrence,development and immunotherapy in T1DM were reviewed.
作者 李世兰 薛君力 LI Shilan;XUE Junli(Jingzhou Hospital Affiliated to Yangtze University,Jingzhou 434020,China)
出处 《国际免疫学杂志》 CAS 2024年第2期213-217,共5页 International Journal of Immunology
关键词 CD137-CD137L 免疫治疗 1型糖尿病 CD137-CD137L Immunotherapy Type 1 diabetes
  • 相关文献

参考文献4

二级参考文献18

共引文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部